Cancer Research AACR Membership  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 69, 203, January 1, 2009. doi: 10.1158/0008-5472.CAN-08-1705
© 2009 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simma, O.
Right arrow Articles by Stoiber, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simma, O.
Right arrow Articles by Stoiber, D.

Immunology

Identification of an Indispensable Role for Tyrosine Kinase 2 in CTL-Mediated Tumor Surveillance

Olivia Simma1, Eva Zebedin1, Nina Neugebauer1, Carola Schellack1, Andreas Pilz3, Souyet Chang-Rodriguez4, Karen Lingnau5, Eva Weisz1,6, Eva Maria Putz1, Winfried F. Pickl2, Thomas Felzmann4, Mathias Müller7,8, Thomas Decker3, Veronika Sexl1 and Dagmar Stoiber1,6

1 Institute of Pharmacology and 2 Institute of Immunology, Medical University of Vienna; 3 Max F. Perutz Laboratories, Department of Microbiology and Immunobiology, University of Vienna; 4 Children's Cancer Research Institute, St. Anna Kinderkrebsforschung; 5 Intercell AG, Campus Vienna Biocenter; 6 Ludwig Boltzmann Institute for Cancer Research; 7 Institute of Animal Breeding and Genetics, Veterinary University of Vienna; and 8 University Center for Biomodels Austria VUW, Vienna, Austria

Requests for reprints: Dagmar Stoiber, Institute of Pharmacology, Medical University of Vienna, Waehringerstrasse 13A, A-1090 Vienna, Austria. Phone: 43-1-4277-64130; Fax: 43-1-4277-9641; E-mail: dagmar.stoiber{at}meduniwien.ac.at.

Key Words: Tyk2 • tumor surveillance • CTL

We showed previously that Tyk2–/– natural killer cells lack the ability to lyse leukemic cells. As a consequence, the animals are leukemia prone. Here, we show that the impaired tumor surveillance extends to T cells. Challenging Tyk2–/– mice with EL4 thymoma significantly decreased disease latency. The crucial role of Tyk2 for CTL function was further characterized using the ovalbumin-expressing EG7 cells. Tyk2–/– OT-1 mice developed EG7-induced tumors significantly faster compared with wild-type (wt) controls. In vivo assays confirmed the defect in CD8+ cytotoxicity on Tyk2 deficiency and clearly linked it to type I IFN signaling. An impaired CTL activity was only observed in IFNAR1–/– animals but not on IFN{gamma} or IL12p35 deficiency. Accordingly, EG7-induced tumors grew faster in IFNAR1–/– and Tyk2–/– but not in IFN{gamma}–/– or IL12p35–/– mice. Adoptive transfer experiments defined a key role of Tyk2 in CTL-mediated tumor surveillance. In contrast to wt OT-1 cells, Tyk2–/– OT-1 T cells were incapable of controlling EG7-induced tumor growth. [Cancer Res 2009;69(1):203–11]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2009 by the American Association for Cancer Research.